Search for: "GLAXOSMITHKLINE" Results 201 - 220 of 1,801
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2011, 5:29 am by David Ingram
Pharma Suits: GlaxoSmithKline says it has settled on the eve of trial a lawsuit alleging its Avandia diabetes drug caused a man to die of a heart attack, avoiding what was to have been the first of 2,000 cases headed... [read post]
31 May 2012, 6:54 am by By MARK SCOTT
The British drug company GlaxoSmithKline is looking to replace the board of Human Genome Sciences, the biotechnology company it is trying to acquire for $2.59 billion, according to people with direct knowledge of the matter. [read post]
1 Jul 2010, 1:19 am by CivPro Blogger
The Legal Intelligencer reports on a recent ruling that GlaxoSmithKline is a citizen of Pennsylvania (where it has its corporate headquarters), preventing removal of a products liability case to federal court. [read post]
19 Feb 2009, 4:19 am
GlaxoSmithKline's venture arm led the funding round. [read post]
2 Mar 2011, 2:33 pm by Sue Reisinger
Federal prosecutors have pursued a 'massive' probe of off-label marketing of drugs at GlaxoSmithKline, and the indictment of a former associate general counsel is 'just a small piece of it,' according to one of her defense attorneys. [read post]
18 Mar 2011, 12:45 pm by Sue Reisinger
Ex-GlaxoSmithKline in-house counsel Lauren Stevens' pre-trial hearing takes some unexpected twists — with the court unsealing a raft of records that reveal the roles of several other lawyers in the alleged misdeed. [read post]
3 Jul 2012, 11:57 am by Isaac Gorodetski
Gregory Conko, a senior fellow at the Competitive Enterprise Institute, comments on the GlaxoSmithKline settlement where the pharmaceutical company agreed to pay a record $3 billion in fines to settle various criminal and civil charges associated with 10 of the... [read post]
28 Oct 2010, 7:03 am by Ashby Jones
The big law-and-biz headline from Wednesday involved drug maker GlaxoSmithKline, which agreed to pay $750 million and enter a guilty plea to settle charges that it put bad drugs into the stream of commerce. [read post]
8 Mar 2021, 11:30 am by D Daniel Sokol
The Application of Competition Law to the Pharmaceutical Sector in the European Union David W Hull, Michael J Clancy Key Points In its seminal judgment in GlaxoSmithKline (paroxetine), the CJEU established the governing principles for assessing the compatibility of reverse-payment... [read post]
18 Oct 2009, 2:43 am
In the first Paxil birth defect case to go to trial, jurors heard testimony late last month that manufacturer GlaxoSmithKline (GSK) was aware of reports of birth defects from mothers who took the antidepressant while pregnant but withheld the information from the FDA and consumers. [read post]
24 Feb 2010, 9:12 am by Jeffrey J. Kroll
According to the report, the manufacturer of the drug, GlaxoSmithKline, knew of the risks associated with the drug for years but worked to keep them from the public. [read post]
15 Jul 2010, 7:46 am
Many Georgians have taken the drug Avandia which was heavily promoted as a treatment option for diabetes by its manufacturer, GlaxoSmithKline. [read post]
11 Mar 2010, 9:07 am by Carey, Danis & Lowe, L.L.C.
As we discussed in our previous blog entry, information has surfaced that suggests GlaxoSmithKline tried to bury evidence that the antidepressant was linked to birth defects when the drug was prescribed to pregnant women. [read post]
20 Feb 2010, 8:53 pm by Angel Reyes
  The report from the investigation is highly critical of GlaxoSmithKline. [read post]
16 Jun 2011, 11:17 am
Like nearly all of the personal injury lawsuits facing GlaxoSmithKline, the latest Avandia complaint alleges improper marketing. [read post]
1 Jun 2011, 4:41 pm by Dan Hargrove
From Pharmalot:And still another state attorney general has filed a lawsuit charging GlaxoSmithKline with fraudulently marketing its controversial Avandia diabetes pill. [read post]
17 Dec 2008, 1:00 pm
It was released in 1992 by the pharmaceutical company GlaxoSmithKline. [read post]